The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.

[1]  O. Valenta,et al.  Gynecologic oncology , 1990 .

[2]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[3]  J. Grudzinskas,et al.  Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. , 1993, BMJ.

[4]  M. McKay,et al.  Cancer of the ovary. , 1994, The New England journal of medicine.

[5]  Usha Menon,et al.  Progress and Challenges in Screening for Early Detection of Ovarian Cancer* , 2004, Molecular & Cellular Proteomics.

[6]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[7]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[8]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[9]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. J. Simard,et al.  Tumour-related microRNAs functions in Caenorhabditis elegans , 2006, Oncogene.

[12]  Peter A. Jones,et al.  Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.

[13]  S. Verhoef,et al.  CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. , 2006, Gynecologic oncology.

[14]  A. Berchuck,et al.  Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study. , 2006, Gynecologic oncology.

[15]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[16]  C. Croce,et al.  MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.

[17]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[18]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[19]  D. Iliopoulos,et al.  E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.

[20]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[21]  A. Harris,et al.  Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.

[22]  T. Leung,et al.  Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.

[23]  Jae Hoon Kim,et al.  MicroRNA Expression Profiles in Serous Ovarian Carcinoma , 2008, Clinical Cancer Research.

[24]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[25]  Artemis G. Hatzigeorgiou,et al.  Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer , 2008, Proceedings of the National Academy of Sciences.

[26]  G. Calin,et al.  Expression and function of micro RNAs in immune cells during normal or disease state , 2008, International journal of medical sciences.

[27]  J. Tostain,et al.  Elevated serum-circulating RNA in patients with conventional renal cell cancer. , 2008, Anticancer research.

[28]  J. Mendell miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.

[29]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.